Larimar Therapeutics
LRMR
#7804
Rank
NZ$0.76 B
Marketcap
NZ$7.33
Share price
7.48%
Change (1 day)
15.46%
Change (1 year)

Earnings for Larimar Therapeutics (LRMR)

Earnings in 2026 (TTM): -NZ$0.29 Billion

According to Larimar Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -NZ$0.29 Billion a decrease over its 2024 earnings that were of -NZ$0.14 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Larimar Therapeutics from 2020 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$0.29 Billion1.09%
2025 -NZ$0.29 Billion105.54%
2024 -NZ$0.14 Billion118.15%
2023 -NZ$62.8 Million4.51%
2022 -NZ$60.09 Million-30.18%
2021 -NZ$86.07 Million19.19%
2020 -NZ$72.21 Million